TY  - RPRT
TI  - A quadrivalent vaccine against serogroup B meningococcal disease: a cost-effectiveness study
AU  - Hanquet Germaine
AU  - Christensen Hannah
AU  - Agnew Emily
AU  - Trotter Caroline
AU  - Robays Jo
AU  - Dubois Cécile
AU  - Devriese Stephan
AU  - Van De Sande Stefaan
AU  - Thiry Nancy
AB  -  KCE Reports 231C (2014)
T2  - KCE Reports
CY  - Brussels
PY  - 2014
LA  - English
M3  - Health Technology Assessment (HTA)
PB  - Belgian Health Care Knowledge Centre (KCE)
SN  - 231
VO  - D/2014/10.273/77
DO  - https://doi.org/10.57598/R231C
ER -